1

October 1, 2007 ICD-9-CM Changes Webcast

September 27, 2007

Sandy Giangreco, CPC, CPC-H

Coding & Reimbursement Educator/Regional Membership Director Wisconsin Medical Society, Copyright 2007

CPT codes, descriptions and material only are Copyright 2006 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in

applicable FARS/DFARS restrictions to government use

2

What is the impact for FY 2008?

144 New Diagnosis Codes17 Deleted Diagnosis Codes5 Revised Diagnosis Codes

• Remember – We no longer have a grace period!!!! • Get these codes loaded and ready to go for

encounters for dos 10.1.2007 and after!

Let’s Get Excited and Get Started!

Let the Fun Begin!

3

Rationale of Coding Changes

• Greater specificity– Some due to technology

• More of the “NOS” or “Unspecified” code sets are subdivided into specific categories in preparation for our conversion to ICD-10

• New technologies require tracking for effectiveness in dealing with disease or for complications of the new technologies– ICD-9 Procedures will not be discussed during

our session today

4

New Subcategory 040.4 Other specified botulism

• Non-foodborne intoxication due to toxins of Clostridium botulinum [C. botulinum] – Excludes: botulism NOS (005.1)

food poisoning due to toxins of Clostridium

botulinum (005.1)

• New code 040.41 Infant botulism • New code 040.42 Wound botulism

– Non-foodborne botulism NOS • Use additional code to identify complicated

open wound

5

From a Clinical Perspective

S/S of infant botulisminclude:• Constipation• Floppy weakness due to

muscle weakness, and trouble controlling the head

• Weak cry• Drooping of eyelids• Tiredness• Difficulty sucking or

feeding• Paralysis

S/S of food-borne and

wound botulism include:• Difficulty swallowing or

speaking• Facial weakness• Double vision• Trouble breathing• Nausea, vomiting and

abdominal cramps• Paralysis

6

New Codes for Viral Illnesses• New Section and Category: OTHER HUMAN

HERPES VIRUSES 058 • New 058 Other human herpes virus category

– Excludes: congenital herpes (771.2) cytomegalovirus (078.5) Epstein-Barr virus (075) herpes NOS (054.0-054.9) herpes simplex (054.0-054.9) herpes zoster (053.0-053.9) human herpesvirus NOS (054.0-054.9) human herpesvirus 1 (054.0-054.9)

human herpesvirus 2 (054.0-054.9) human herpesvirus 3 (052.0-053.9)

human herpesvirus 4 (075) human herpesvirus 5 (078.5) varicella (052.0-052.9)

varicella-zoster virus (052.0-053.9)

7

Roseola Infantum

• New code 058.10 Roseola infantum, Exanthema subitum [sixth disease], unspecified

• New code 058.11 Roseola infantum due to human herpes virus 6

• New code 058.12 Roseola infantum due to human herpes virus 7

8

New Herpes Encephalitis Codes

• New subcategory 058.2 Other human herpes virus encephalitis – Excludes: herpes encephalitis NOS (054.3)

herpes simplex encephalitis (054.3) human herpes virus encephalitis NOS (054.3)

simian B herpes virus encephalitis (054.3)

• New code 058.21 Human herpes virus 6 encephalitis

• New code 058.29 Other human herpes virus encephalitis – Human herpesvirus 7 encephalitis

9

More Herpes Codes

• New subcategory 058.8 Other human herpes virus infections

• New code 058.81 Human herpes virus 6 infection • New code 058.82 Human herpes virus 7 infection • New code 058.89 Other human herpes virus

infection – Human herpes virus 8 infection

• Kaposi’s sarcoma-associated herpes virus infection

10

Respiratory System Virus

• New code 079.83 Parvovirus B19 • AKA: Human parvovirus

Parvovirus NOS – Excludes: erythema infectiosum [fifth disease]

(057.0)

www.accesskent.com www.robynsnest.com

11

Clinical Aspects of Viral Illnesses• DNA Analysis is being used to identify more

diseases and further differentiating the viruses causing those

• Two variants of the herpes virus 6-A causes no disease, B can cause roseola

• Varying severities are seen with roseola– Most have no symptoms– May be cause of febrile convulsions– Can be as severe as encephalitis and failure of organs– Dangerous to immunocompromised patients

• May use antiviral drugs such as gancyclovir or acyclovir in patients with pityriasis, also caused by these viruses

12

Clinical Information about Human Herpes Virus

• Signs and Symptoms include: Rash or roseola, and chronic fatigue syndrome

• Roseola infantum – the patient may not have any noticable symptoms

• If the patient develops encephalitis (maybe they are immunocompromised) they may become symptomatic the day after the disease is gone

13

Lymphoma Code Changes • Lymphomas have been named by their discoverer,

or by some difference in their activity, related to their diseases or manifestations

• Recently these were divided in to 4 categories:– Hodgkin’s– High-Grade – Intermediate Grade– And Low Grade Non-Hodgkin’s Lymphoma

• World Health Organization (WHO) has standardized the nomenclature proposed by the Revised European-American Lymphoma classification (REAL)

14

Clinical Aspects of REAL

• First classified by cell type – the cell which, if it is normal, most closely looks like the tumor cell– B-cell tumors– T-cell tumors– Natural killer cell tumors – And other minor tumors

www.bbc.co.uk

15

Mature B-Cell Tumors (NHL) • Chronic lymphocytic leukemia/small lymphocytic lymphoma• B-cell prolymphocytic leukemia• Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia• Splenic marginal zone lymphoma• Plasma cell neoplasms – plasma cell myeloma, plasmacytoma, heavy

chain diseases, monoclonal deposit disease• Extranodal marginal zone B cell lymphoma (mucosa associated

lymphoid tissue, MALT lymphoma) • Nodal marginal zone B cell lymphoma• Follicular lymphoma• Mantle cell lymphoma• Diffuse large B cell lymphoma• Mediastinal (thymic) large B cell lymphoma• Intravascular large B cell lymphoma• Primary effusion lymphoma• Burkitt lymphoma/leukemia• Lymphomatoid granulomatosis

16

Mature T-Cell and Natural Killer Cell Tumors (NHL)

• T cell prolymphocytic leukemia• T cell large granular lymphocytic leukemia• Aggressive NK cell leukemia• Adult T cell leukemia/lymphoma• Extranodal NK/T cell lymphoma, nasal type• Enteropathy-type T cell lymphoma• Hepatosplenic T cell lymphoma• Blastic NK cell lymphoma• Mycosis fungoides/Sezary syndrome• Primary cutaneous CD30-positive T cell lymphoproliferative disorders

– Primary cutaneous anaplastic large cell lymphoma– Lymphomatoid Papulosis

• Angioimmunoblastic T cell lymphoma• Peripheral T cell lymphoma, unspecified• Anaplastic large cell lymphoma

17

Hodgkin’s Lymphoma

• Nodular lymphocyte-predominant Hodgkin lymphoma

• Classical Hodgkin lymphoma– Nodular sclerosis– Mixed cellularity– Lymphocyte-rich – Lymphocyte depleted or not depleted

www.medstudents.com.br

18

Immunodeficiency-Associated Lymphoproliferative Disorders

• Associated with a primary immune disorder

• Associated with the Human Immunodeficiency Virus (HIV)

• Post-transplant

• Associated with Methotrexate therapy

19

Histiocytic and Dendritic Cell Neoplasms (CNS)

• Histiocytic sarcoma

• Langerhans cell histiocytosis

• Langerhans cell sarcoma

• Interdigititating dendritic cell sarcoma/tumor

• Follicular dendritic cell sarcoma/tumor

• Dendritic cell sarcoma, unspecified

20

Classification by Immunologic Subtype and Aggressiveness

• B Cell– Small lymphocytic– Lymphoplasmacytic– Follicular– Marginal zone, MALT– Marginal zone, nodal– Mantle cell– Diffuse large B cell– Primary mediastinal large B

cell– Burkitt’s like

• T Cell– Peripheral T–cell– Anaplastic large T/null

cell– lymphoblastic

21

Revision to Code 200

• Revise 200 Lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue

22

Our New Subdivisions for Lymphomas

• 200.3X Marginal zone• 200.4X Mantle zone• 200.5X Primary CNS• 200.6X Anaplastic

large cell• 200.7X Large cell

Lymphoma• 200.8X Peripheral T-

cell

• .X0 Unspecified site• .X1 Head, face, neck

nodes• .X2 Intrathoracic nodes• .X3 Intra-abdominal nodes• .X4 Nodes axilla, upper

limb• .X5 Inguinal, lower limb• .X6 Pelvic nodes• .X7 Spleen• .X8 Multiple Sites

23

Further Breakdown of These Codes

• 200.3X Marginal Zone Lymphoma – typically indolent and accounts for approx. 10% of all lymphomas

• 200.4X Mantle Cell Lymphoma – aggressive tumor type and represents about 6% of all lymphomas– Typically described as incurable with traditional tx but stem cell

transplant may be provided

• 200.5X Primary CNS Lymphoma – also aggressive type but only accounts for about 1-2% of all cases– Requires different chemo options than other NHL’s and in many

cases also requires radiation to brain.

24

More Information • 200.6X Anaplastic Large Cell Lymphoma – also

aggressive and accounts for 2% of all lymphomas. – Pts are tested for ALK-1 which is fusion protein.

• 200.7X Large Cell Lymphoma – considered very aggressive, grows extremely quickly and accounts for approximately 20-30% of all lymphomas

• Metastatic lymph node tumors are classified to category 196.X (Secondary and unspecified malignant neoplasm of lymph node)

25

Peripheral T-Cell Lymphoma

• New code 202.7X Peripheral T-cell lymphoma

• .X0 Unspecified site• .X1 Head, face, neck

nodes• .X2 Intrathoracic nodes• .X3 Intra-abdominal nodes• .X4 Nodes axilla, upper

limb• .X5 Inguinal, lower limb• .X6 Pelvic nodes• .X7 Spleen• .X8 Multiple Sites

26

Carcinoma In-Situ (CIS)

• Deleted 233.3 – other and unspecified- greater specificity desired with HPV connection with CIS

• New code 233.30 Unspecified female genital organ • New code 233.31 Vagina

– Severe dysplasia of vagina – Vaginal intraepithelial neoplasia III [VAIN III]

• New code 233.32 Vulva – Severe dysplasia of vulva – Vulvar intraepithelial neoplasia III [VIN III]

• New code 233.39 Other female genital organ

27

Endocrine Specific Codes • Deleted 255.4 Corticoadrenal insufficiency which

included both glucocorticoid (cortisone, etc.) and mineralocorticoid (aldosterone, etc.) problems

• New code 255.41 Glucocorticoid deficiency • Addisonian crisis • Addison’s disease NOS • Adrenal atrophy (autoimmune) • Adrenal calcification • Adrenal crisis • Adrenal hemorrhage • Adrenal infarction • Adrenal insufficiency NOS

– Combined glucocorticoid and mineralocorticoid deficiency – Corticoadrenal insufficiency NOS

• New code 255.42 Mineralocorticoid deficiency Hypoaldosteronism – Excludes: combined glucocorticoid and

mineralocorticoid deficiency (255.41)

28

Clinical Perspective of Endocrine Changes

• The adrenal cortex produces 50 hormones including 98% of the corticosteroids (mostly cortisone) and mineralcorticoids (mostly aldosterone)

• Adrenal medulla produces adrenaline (epi and norepi)• Primary adrenal insufficiency includes lack of production of

both cortisones (corticosteroids) and mineralcorticoids • Secondary retains production of mineralcorticoids

29

Clinical Aspects of Hormones

• Effects of corticosteroids– Stimulates production of

glucose from protein (glucogenesis) and decreases cellular glucose usage

– Mobilizes amino acids– Increases pts red cell and

platelet counts– Inhibits effects of insulin– Massive effects in

inflammation to fight SIRS

• Effects of aldosterone– Responds to renin

angiotensin cycle in maintenance of blood pressure

– Effect on kidneys, intestines, sweat glands to maintain electrolyte balance

– Excesses of aldosterone result in picture of sodium retention, hypokalemia and alkalosis

30

2 types of Adrenal Insufficiency

• Primary Adrenal Insufficiency– Reduction of both

aldosterone and cortisol– Results from destruction

of adrenal glands (TB, fungal replacement, hemorrhage, malignancy)

– May result from congenital hypoplasia or from toxicity to adrenal glands

• Secondary Adrenal Insufficiency– Pituitary tumors, not

stimulating adrenals to produce the hormones

– Long term usage of steroids clinically as in chemo, COPD, allergic dx and autoimmune dz

31

Acute Adrenal Insufficiency

• Can result in shock and possible rapid death• May result from rapid cessation of long term

steroid usage • Can result from sepsis or surgical stresses• Most common known cause of hemorrhage is

Waterhouse Friedrichsen syndrome – bilateral adrenal hemorrhages from menigococcemia

• Autoimmmune adrenal insufficiency likely will have its own breakdown of polyglandular autoimmune disorders (PGA’s) codes in future

32

Actual Codes• New code 255.41 Glucocorticoid deficiency

– Addisonian crisis – Addison’s disease NOS – Adrenal atrophy (autoimmune) – Adrenal calcification – Adrenal crisis – Adrenal hemorrhage – Adrenal infarction – Adrenal insufficiency NOS

• Combined glucocorticoid and mineralocorticoid deficiency • Corticoadrenal insufficiency NOS

• New code 255.42 Mineralocorticoid deficiency – Hypoaldosteronism

• Excludes: combined glucocorticoid and mineralocorticoid deficiency (255.41)

33

A Few Good MEN

• New code 258.01 Multiple endocrine neoplasia [MEN] type I – Wermer’s syndrome

• New code 258.02 Multiple endocrine neoplasia [MEN] type IIA – Sipple’s syndrome

• New code 258.03 Multiple endocrine neoplasia [MEN] type IIB

– Use additional codes to identify any malignancies and other conditions associated with the syndromes

34

MEN May be in Women

• Long known groupings of endocrine tumors with genetic cause

• MEN I – parathyroid adenomas causing hyperparathyroidism, kidney stones, pancreatic adenomas, anterior pituitary tumors and skin tumors

• Mostly benign but can have malignancy

35

MEN May be in Women cont.

• MEN II – Medullary carcinoma of thyroid [bad acting thyroid cancer, worse than papillary or follicular], pheochromocytoma [excessive adrenaline and dangerous hypertension] of adrenal gland– IIA may also have hyperparathyroidism [with

kidney stones] due to parathyroid adenoma– IIB won’t

36

New Anemia Codes • New code 284.81 Red cell aplasia (acquired)

(adult) (with thymoma) – Red cell aplasia NOS

• New code 284.89 Other specified aplastic anemias – Aplastic anemia (due to):

• chronic systemic disease • drugs • infection • radiation • toxic (paralytic)

– Use additional E code to identify cause

37

One solo Code

• New code 288.66 Bandemia – Bandemia without diagnosis of specific infection

• Excludes: confirmed infection – code to infection leukemia (204.00-208.9)

38

Developmental Delays

• New code 315.34 Speech and language developmental delay due to hearing loss – Use additional code to identify type of

hearing loss (389.00-389.9)

39

Hydrocephalus Code

• New code 331.5 Idiopathic normal pressure hydrocephalus (INPH) – Normal pressure hydrocephalus NOS

• Excludes: congenital hydrocephalus (742.3) secondary normal pressure hydrocephalus

(331.3) spina bifida with hydrocephalus (741.0)

40

Myotonic Conditions • New code 359.21 Myotonic muscular dystrophy

• Dystrophia myotonica • Myotonia atrophica • Myotonic dystrophy • Proximal myotonic myopathy (PROMM) • Steinert’s disease

• New code 359.22 Myotonia congenita • Acetazolamide responsive myotonia congenita • Dominant form (Thomsen’s disease) • Recessive form (Becker’s disease)

• New code 359.23 Myotonic chondrodystrophy • Congenital myotonic chondrodystrophy • Schwartz-Jampel disease

• New code 359.24 Drug-induced myotonia • Use additional E code to identify drug

• New code 359.29 Other specified myotonic disorder • Myotonia fluctuans • Myotonia levior • Myotonia permanens • Paramyotonia congenita (of von Eulenburg)

41

Clinical Perspective

• Excessive tone or spasms to muscles, impairs movements

• Myotonic muscular dystrophy is most common form of adult onset MD – high risk during and after anesthesia

• Drug induced known adverse effect of Lasix (furosemide) and Atromid-S (clofibrate)

42

Floppy Iris Syndrome

• Variant of small pupil syndrome• A complication of TV ads – telling men to ask their

physicians for drugs• Alpha-1 blocking agents are present in some

antihypertensives and is present as Flomax• Patients undergoing cataract surgery by

phacoemulsification are in danger of permanent small pupils because of flaccid iris and drugs usually used in surgery

• Can be prevented (if known) with iris hooks and dilators

43

Eye Codes

• New code 364.81 Floppy iris syndrome – Intraoperative floppy iris syndrome (IFIS) – Use additional E code to identify cause, such

as: sympatholytics [antiadrenergics] causing adverse effect in therapeutic use (E941.3)

• New code 364.89 Other disorders of iris and ciliary body – Prolapse of iris NOS

• Excludes: prolapse of iris in recent wound (871.1)

44

Hearing Codes • New code 388.45 Acquired auditory processing

disorder – Auditory processing disorder NOS

• Excludes: central auditory processing disorder (315.32)

• New code 389.05 Conductive hearing loss, unilateral

• New code 389.06 Conductive hearing loss, bilateral

• New code 389.13 Neural hearing loss, unilateral • New code 389.17 Sensory hearing loss, unilateral

45

More Hearing Codes

• New code 389.20 Mixed hearing loss, unspecified

• New code 389.21 Mixed hearing loss, unilateral

• New code 389.22 Mixed hearing loss, bilateral

46

Cardiac Codes

• New Code 414.2 Chronic total occlusion of coronary artery – Complete occlusion of coronary artery – Total occlusion of coronary artery – Code first coronary atherosclerosis (414.00-

414.07) • Excludes: acute coronary occlusion with

myocardial infarction (410.00-410.92)

acute coronary occlusion without myocardial

infarction (411.81)

47

Septic Embolism

• Septic embolism is a venous blood clot that can be present because of stasis from prolonged occlusion, inflammation (phlebitis) or infection.

• A venous clot in the peripheral circulation can embolize to the lungs

• A clot in the left side of the heart or originating from an infected mitral or aortic valve can embolize to the arteries in the periphery (legs, organs, brain, etc)

• Such an infected clot is a septic embolus. If it goes to the brain – stroke, if leg- causes dead leg.

48

Septic Embolism Codes

• New code 415.12 Septic pulmonary embolism – Septic embolism NOS

• Code first underlying infection, such as: septicemia (038.0-038.9) – Excludes: septic arterial embolism (449)

• New code 449 Septic arterial embolism – Code first underlying infection, such as: infective

endocarditis (421.0), lung abscess (513.0) – Use additional code to identify the site of the embolism

(433.0-433.9, 444.0-444.9) – Excludes: septic pulmonary embolism (415.12)

49

Septic Embolism • 415.12 is septic pulmonary embolism – from

peripheral venous circulatory system, usually related to an indwelling venous access device, through the right heart to the lungs

• 449 is septic arterial embolism, from the left side of heart OR heart valves from endocarditis, through the aorta – even more rare would be an infected venous clot going through an atrial septal defect

50

More Heart Codes

• New code 423.3 Cardiac tamponade – Code first the underlying cause

• New code 440.4 Chronic total occlusion of artery of the extremities – Complete occlusion of artery of the extremities – Total occlusion of artery of the extremities

• Code first atherosclerosis of arteries of the extremities (440.20-440.29, 440.30-440.32)

– Excludes: acute occlusion of artery of extremity (444.21- 444.22)

51

Influenza

• New code 488 Influenza due to identified avian influenza virus

• Note: Influenza caused by influenza viruses that normally infect only birds and, less commonly, other animals

• Excludes: influenza caused by other influenza viruses (487)

52

Dental Codes • New code 525.71 Osseointegration failure of dental implant

• Hemorrhagic complications of dental implant placement • Iatrogenic osseointegration failure of dental implant • Osseointegration failure of dental implant due to complications of

systemic disease • Osseointegration failure of dental implant due to poor bone quality • Pre-integration failure of dental implant NOS • Pre-osseointegration failure of dental implant

• New code 525.72 Post-osseointegration biological failure of dental implant

• Failure of dental implant due to lack of attached gingiva • Failure of dental implant due to occlusal trauma (caused by poor

prosthetic design) • Failure of dental implant due to parafunctional habits • Failure of dental implant due to periodontal infection (peri-

implantitis) • Failure of dental implant due to poor oral hygiene • Iatrogenic post-osseointegration failure of dental implant • Post-osseointegration failure of dental implant due to complications

of systemic disease

53

More Dental Codes

• New code 525.73 Post-osseointegration mechanical failure of dental implant – Failure of dental prosthesis causing loss of

dental implant – Fracture of dental implant

– Excludes: cracked tooth (521.81) fractured dental restorative material with loss of

material (525.64) fractured dental restorative material without loss

of material (525.63) fractured tooth (873.63, 873.73)

• New code 525.79 Other endosseous dental implant failure – Dental implant failure NOS

54

Anal Sphincter Tear

• New code 569.43 Anal sphincter tear (healed) (old) – Tear of anus, nontraumatic – Use additional code for any associated fecal

incontinence (787.6) • Excludes: anal fissure (565.0)

anal sphincter tear (healed) (old) complicating delivery

(654.8)

55

VIN and CIN are NOT the same

• New code 624.01 Vulvar intraepithelial neoplasia I [VIN I] – Mild dysplasia of vulva

• New code 624.02 Vulvar intraepithelial neoplasia II [VIN II] – Moderate dysplasia of vulva

• New code 624.09 Other dystrophy of vulva – Kraurosis of vulva – Leukoplakia of vulva

56

Anal Sphincter Tear w/ Pregnancy

• New code 664.6X Anal sphincter tear complicating delivery, not associated with third-degree perineal laceration [0,1,4]

• Excludes: third-degree perineal laceration (664.2)

• Must assign 5th digit dependant upon if patient has delivered, still pregnant or unknown

57

Aseptic Necrosis of Bone

• New code 733.45 Aseptic Necrosis of Bone, Jaw – Use additional E code to identify drug, if drug-

induced • Excludes: osteoradionecrosis of jaw (526.89)

58

Hard to Swallow Codes

• New code 787.20 Dysphagia, unspecified – Difficulty in swallowing NOS

• New code 787.21 Dysphagia, oral phase • New code 787.22 Dysphagia, oropharyngeal phase • New code 787.23 Dysphagia, pharyngeal phase • New code 787.24 Dysphagia, pharyngoesophageal phase • New code 787.29 Other dysphagia

– Cervical dysphagia – Neurogenic dysphagia

• Identify what are the issues being assisted

59

Greater Definition of Dysphagias

• 787.21 Oral Phase– Impaired structure/physiology of palate, tongue, lips, cheeks

• 787.22 Oropharyngeal Phase– Impaired structure/physiology of tongue base and pharyngeal walls

• 787.23 Pharyngeal Phase– Impaired structure/physiology of pharynx and larynx

• 787.24 Pharyngoesophageal Phase– Impaired structure/physiology of upper esophageal sphincter

• 787.25 Dysphagia, unspecified – became 787.20

60

Implications of Dysphagia Phases

• Some implications of dysphagia– Aspiration (pneumonia, bronchitis, pneumonitis)– Dehydration– Malnutrition

• Diseases cause various phases to be affected

• Treatments differ, dependent on phase affected

61

Expansion of Ascites

• Code 789.5 Ascites has been deleted• New code 789.51 Malignant ascites

– Code first malignancy, such as: malignant neoplasm of ovary (183.0)

– secondary malignant neoplasm of retroperitoneum and peritoneum (197.6)

• New code 789.59 Other ascites – Right heart failure, cirrhosis, renal failure,

hypothyroidism, peritoneal infections, hypoproteinemia from any source, pancreatitis, congenital deformities of portal vein, liver, heart

62

Clinical Aspect

• Malignant Ascites– Adenocarcinoma deposits on the peritoneum

which cause leakage of fluid– Colon ca, pancreatic ca, liver ca, ovarian ca

– May be active– Clear, yellow fluid– Reaction of infection, outpouring of fluid

63

V Codes • New code V12.53 Sudden cardiac arrest

– Sudden cardiac death successfully resuscitated

• New code V12.54 Transient ischemic attack (TIA), and cerebral infarction without residual deficits – Prolonged reversible ischemic neurological deficit

(PRIND) – Reversible ischemic neurologic deficit (RIND) – Stroke NOS without residual deficits

• Excludes: late effects of cerebrovascular disease (438.0-438.9)

64

OB V Code

• New code V13.22 Personal history of cervical dysplasia – Personal history of conditions classifiable to

622.10-622.12 • Excludes: personal history of malignant

neoplasm of cervix uteri (V10.41)

65

More Family Hx V Codes! • Revise Family history of condition classifiable to

188–189 • New code V16.52 Bladder

• New code V17.41 Family history of sudden cardiac death (SCD)

• Excludes: family history of ischemic heart disease (V17.3) family history of myocardial infarction (V17.3)

• New code V17.49 Family history of other cardiovascular diseases – Family history of cardiovascular disease NOS

66

Endrocrine V Codes

• New code V18.11 Multiple endocrine neoplasia [MEN] syndrome

• New code V18.19 Other endocrine and metabolic diseases

67

Contraception and Procreative Mgmt

• New code V25.04 Counseling and instruction in natural family planning to avoid pregnancy

• New code V26.41 Procreative counseling and advice using natural family planning

• New code V26.49 Other procreative management counseling and advice

• New code V26.81 Encounter for assisted reproductive fertility procedure cycle – Patient undergoing in vitro fertilization cycle – Use additional code to identify the type of infertility

• Excludes: pre-cycle diagnosis and testing – code to reason for encounter • New code V26.89 Other specified procreative mgmt

68

More V Codes! • New code V49.85 Dual sensory impairment

– Blindness with deafness – Combined visual hearing impairment

– Code first: • hearing impairment (389.00-389.9) • visual impairment (369.00-369.9)

• Revised V58.69 Long-term (current) use of other medications

Other hHigh-risk medications

69

Disability Evals/Exams

• New code V68.01 Disability examination – Use additional code(s) to identify:

specific examination(s), screening and testing performed (V72.0-V82.9)

• New code V68.09 Other issue of medical certificates

70

Misc V Codes

• New code V72.12 Encounter for hearing conservation and treatment

• New code V73.81 Human papillomavirus (HPV)

71

Genetic Susceptibility V Codes

• New code V84.81 Genetic susceptibility to multiple endocrine neoplasia [MEN]

• New code V84.89 Genetic susceptibility to other disease

72

New E Codes!!!!!

• New code E928.6 Environmental exposure to harmful algae and toxins

• Includes:– Algae bloom NOS – Blue-green algae bloom – Brown tide – Cyanobacteria bloom – Florida red tide – Harmful algae bloom – Pfisteria piscicida – Red tide

73

E code for Bisphosphonates

• E933 Primarily systemic agents • New code E933.6 Oral bisphosphonates • New code E933.7 Intravenous

bisphosphonates

74

Case Scenarios

75

Case Scenario # 1

• A 58 year old female patient is seen for biopsy of masses found in both the chest and her groin lymph nodes. The pathology report comes back as nodal marginal zone B-cell lymphoma. What would the appropriate diagnosis be for this patient?

A. 200.38

B. 195.1, 200.35

C. 200.23, 200.35

D. 200.83

76

Case Scenario # 2

• Patient is admitted to the Emergency Room after having spent the day at the beach. Family members stated that they told him to stay out of the water due to the blue green algae that had been reported at the lake. What is the appropriate E code to use for the ER visit?

A. E926.0B. E928.6 C. E999D. E927

77

Case Scenario # 3

• 45 year old patient presents to the clinic for a work-up of left lower quadrant abdominal pain. He has Peripheral T-Cell lymphoma of the axilla, in remission. At the beginning of the encounter (before any radiology findings are available from the hospital radiology department) what would the diagnosis code be for this encounter?

A. 202.74, 789.04B. 789.00, 202.70C. 789.04, V10.79D. 789.04, 202.74

78

Resources

• ICD-9-CM Book 2008 published by Ingenix• http://www.cdc.gov/nchs/datawh/ftpserv/ftpicd9/icdt

ab_addenda08.pdf• HcPro Audioconference “The Impact of the New

and Revised 2008 ICD-9-CM Diagnosis and Procedure Codes” 8.24.07

• Advance Magazine 7.16.07 issue Coding for Non-Hodgkin’s Lymphoma

• AAPC Coding Edge August 2007 issue “What’s Your ICD-9 Game Plan” by Catherine Gray, RHIT, CCS, CPC, CPC-CS

79

Sandy Giangreco, CPC, CPC-H

Coding & Reimbursement Educator/Membership Director

Sandyg@wismed.org

608-442-3776

Thank You

80

The information presented and responses to the questions posed are not intended to serve as coding or legal advice. Many variables affect coding

decisions and any response to the limited information provided in a question is intended only to provide general information that might be

considered in resolving coding issues. All coding must be considered on a case-by-case basis and must be supported by appropriate documentation

in the medical record. Therefore, the Wisconsin Medical Society recommends consulting directly with payers to determine specific payers’ guidance regarding appropriate coding and claim submission. The CPT codes that are utilized in coding claims are produced and copyrighted by

the American Medical Association (AMA). Specific questions regarding the use of CPT codes may be directed to the AMA.

Disclaimer